Latest Insider Transactions at Willis Towers Watson PLC (WTW)
This section provides a real-time view of insider transactions for Willis Towers Watson PLC (WTW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of WILLIS TOWERS WATSON PLC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of WILLIS TOWERS WATSON PLC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 11
2021
|
Anna C Catalano Director |
SELL
Payment of exercise price or tax liability
|
Direct |
386
-6.38%
|
$101,904
$264.25 P/Share
|
|
May 11
2021
|
Wilhelm Zeller Director |
BUY
Grant, award, or other acquisition
|
Direct |
605
+6.25%
|
-
|
|
May 11
2021
|
Wilhelm Zeller Director |
SELL
Payment of exercise price or tax liability
|
Direct |
687
-7.5%
|
$181,368
$264.25 P/Share
|
|
May 11
2021
|
Victor F Ganzi Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,646
+6.95%
|
-
|
|
May 11
2021
|
Victor F Ganzi Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,049
-4.89%
|
$276,936
$264.25 P/Share
|
|
May 11
2021
|
Wendy E Lane Director |
BUY
Grant, award, or other acquisition
|
Direct |
605
+7.08%
|
-
|
|
May 11
2021
|
Wendy E Lane Director |
SELL
Payment of exercise price or tax liability
|
Direct |
386
-5.0%
|
$101,904
$264.25 P/Share
|
|
May 11
2021
|
Brendan R Oneill Director |
BUY
Grant, award, or other acquisition
|
Direct |
605
+4.34%
|
-
|
|
May 11
2021
|
Brendan R Oneill Director |
SELL
Payment of exercise price or tax liability
|
Direct |
386
-2.94%
|
$101,904
$264.25 P/Share
|
|
May 11
2021
|
Jaymin B Patel Director |
BUY
Grant, award, or other acquisition
|
Direct |
605
+9.57%
|
-
|
|
May 11
2021
|
Jaymin B Patel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
386
-7.02%
|
$101,904
$264.25 P/Share
|
|
May 11
2021
|
Paul D Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
605
+5.11%
|
-
|
|
May 11
2021
|
Paul D Thomas Director |
SELL
Payment of exercise price or tax liability
|
Direct |
386
-3.5%
|
$101,904
$264.25 P/Share
|
|
May 11
2021
|
Linda D Rabbitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,078
+6.92%
|
-
|
|
May 11
2021
|
Linda D Rabbitt Director |
SELL
Payment of exercise price or tax liability
|
Direct |
386
-2.8%
|
$101,904
$264.25 P/Share
|
|
Apr 15
2021
|
Nicolas Aubert Head of Great Britain |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.11%
|
-
|
|
Apr 15
2021
|
Anne Pullum Head of Europe |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.12%
|
-
|
|
Apr 15
2021
|
Gene H Wickes Head of Benefits Deliv & Admin |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.03%
|
-
|
|
Apr 15
2021
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.02%
|
-
|
|
Apr 15
2021
|
Michael J Burwell Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
38
+0.13%
|
-
|
|
Apr 15
2021
|
Carl Aaron Hess Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.05%
|
-
|
|
Apr 15
2021
|
Matthew Furman General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
19
+50.0%
|
-
|
|
Apr 15
2021
|
Anne Donovan Bodnar Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.1%
|
-
|
|
Apr 15
2021
|
Joseph Gunn Head of North America |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.06%
|
-
|
|
Apr 15
2021
|
Adam Garrard Head of Risk & Broking |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.09%
|
-
|
|
Apr 02
2021
|
Susan Dorrance Davies PAO and Controller |
SELL
Sale (or disposition) back to the issuer
|
Direct |
646
-27.44%
|
$144,704
$224.98 P/Share
|
|
Apr 02
2021
|
Susan Dorrance Davies PAO and Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
646
+21.53%
|
-
|
|
Feb 21
2021
|
Anne Pullum Head of Europe |
BUY
Grant, award, or other acquisition
|
Direct |
5,085
+29.51%
|
-
|
|
Feb 21
2021
|
Michael J Burwell Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,848
+31.2%
|
-
|
|
Feb 21
2021
|
Matthew Furman General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,423
+19.9%
|
-
|
|
Feb 21
2021
|
Joseph Gunn Head of North America |
BUY
Grant, award, or other acquisition
|
Direct |
5,138
+16.7%
|
-
|
|
Feb 21
2021
|
Adam Garrard Head of Risk & Broking |
BUY
Grant, award, or other acquisition
|
Direct |
5,390
+22.85%
|
-
|
|
Feb 21
2021
|
Nicolas Aubert Head of Great Britain |
BUY
Grant, award, or other acquisition
|
Direct |
7,673
+27.64%
|
-
|
|
Feb 21
2021
|
Anne Donovan Bodnar Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
121
-0.3%
|
$27,104
$224.98 P/Share
|
|
Feb 21
2021
|
Anne Donovan Bodnar Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,310
+11.36%
|
-
|
|
Feb 21
2021
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Payment of exercise price or tax liability
|
Direct |
193
-0.19%
|
$43,232
$224.98 P/Share
|
|
Feb 21
2021
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Grant, award, or other acquisition
|
Direct |
8,351
+7.61%
|
-
|
|
Feb 21
2021
|
Gene H Wickes Head of Benefits Deliv & Admin |
SELL
Payment of exercise price or tax liability
|
Direct |
193
-0.27%
|
$43,232
$224.98 P/Share
|
|
Feb 21
2021
|
Gene H Wickes Head of Benefits Deliv & Admin |
BUY
Grant, award, or other acquisition
|
Direct |
8,351
+10.06%
|
-
|
|
Feb 21
2021
|
Carl Aaron Hess Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
185
-0.4%
|
$41,440
$224.98 P/Share
|
|
Feb 21
2021
|
Carl Aaron Hess Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,030
+14.34%
|
-
|
|
Nov 09
2020
|
Gene H Wickes Head of Benefits Deliv & Admin |
BUY
Bona fide gift
|
Indirect |
280
+6.3%
|
-
|
|
Nov 09
2020
|
Gene H Wickes Head of Benefits Deliv & Admin |
SELL
Bona fide gift
|
Direct |
1,630
-1.2%
|
-
|
|
Nov 10
2017
|
Jeffrey W Ubben Director |
SELL
Open market or private sale
|
Indirect |
120,000
-5.08%
|
$19,320,000
$161.39 P/Share
|
|
Nov 09
2017
|
Jeffrey W Ubben Director |
SELL
Open market or private sale
|
Indirect |
320,000
-11.92%
|
$51,520,000
$161.15 P/Share
|
|
Oct 13
2017
|
Jeffrey W Ubben Director |
SELL
Open market or private sale
|
Indirect |
128,237
-4.56%
|
$20,133,209
$157.34 P/Share
|
|
Oct 12
2017
|
Jeffrey W Ubben Director |
SELL
Open market or private sale
|
Indirect |
103,578
-3.55%
|
$16,158,168
$156.36 P/Share
|
|
Oct 11
2017
|
Jeffrey W Ubben Director |
SELL
Open market or private sale
|
Indirect |
55,717
-1.87%
|
$8,691,852
$156.04 P/Share
|
|
Oct 06
2017
|
Jeffrey W Ubben Director |
SELL
Open market or private sale
|
Indirect |
8,118
-0.27%
|
$1,266,408
$156.05 P/Share
|
|
Sep 27
2017
|
Jeffrey W Ubben Director |
SELL
Open market or private sale
|
Indirect |
1,200
-0.04%
|
$187,200
$156.01 P/Share
|